Repathahcp.com
Top path sites |
Top hcp sites |
- Title
- Reduce risk of MI and stroke in patients with established CVD | Repatha® (evolocumab)
- Meta Description
- Learn about PCSK9 inhibitor Repatha® (evolocumab) and ways it reduces risk of stroke and myocardial infarction in your patients with established CVD.
- Meta Keywords
- Technologies in use
- Google Analytics, jQuery
Cache-Control | no-cache, no-store |
Pragma | no-cache |
Content-Type | text/html; charset=u |
Content-Encoding | gzip |
Expires | -1 |
Vary | Accept-Encoding |
Content-Security-Policy | frame-ancestors 'sel |
X-Frame-Options | ALLOW-FROM http://ww |
X-Xss-Protection | 1; mode=block |